The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data


Variant: NM_001369369.1(FOXN1):c.246C>A (p.Cys82Ter)

CA398320910

2780381 (ClinVar)

Gene: FOXN1
Condition: T-cell immunodeficiency, congenital alopecia, and nail dystrophy
Inheritance Mode: Semidominant inheritance
UUID: 7b2de6b9-9cde-4011-afe0-6bf5073780e9
Approved on: 2024-09-27
Published on: 2025-02-20

HGVS expressions

NM_001369369.1:c.246C>A
NM_001369369.1(FOXN1):c.246C>A (p.Cys82Ter)
NC_000017.11:g.28524625C>A
CM000679.2:g.28524625C>A
NC_000017.10:g.26851643C>A
CM000679.1:g.26851643C>A
NC_000017.9:g.23875770C>A
NG_007260.1:g.5685C>A
ENST00000577936.2:c.246C>A
ENST00000579795.6:c.246C>A
ENST00000226247.2:c.246C>A
ENST00000481916.6:c.*1196-68516G>T
ENST00000577936.1:c.246C>A
ENST00000579795.5:c.246C>A
NM_003593.2:c.246C>A
NM_003593.3:c.246C>A
More

Pathogenic

Met criteria codes 3
PVS1 PP4 PM2_Supporting
Not Met criteria codes 1
PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for FOXN1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
NM_001369369.1(FOXN1):c.246C>A (p.Cys82Ter) is a nonsense variant predicted to cause a premature stop codon (3/9) and lead to nonsense mediated decay in a disease that is loss of function (PVS1). The variant has been found in at least one compound heterozygous patient with FOXN1 deficiency (P9, PMID: 33464451). The patient displayed alopecia and low t-cell numbers (less than 1,000,000 cells/L) (PP4). They also had poor proliferative response to phytohemagglutinin on total cells, though normal when evaluated on separated T cells, flow cytometric analysis showed near complete absence of CD45RA+ CD4 T cells, and they had very low TRECs. They received a thymus transplant but T cell levels were not reported post transplant. Interestingly the patients alopecia spontaneously reversed at age 3. The variant is absent from gnomADv4.1 (PM2_supporting). In summary this variant meets criteria to be classified as pathogenic for semidominant T-cell immunodeficiency, congenital alopecia, and nail dystrophy due to FOXN1 deficiency based on the ACMG/AMP criteria applied: PVS1, PM2_supporting, PP4 as specified by the ClinGen SCID VCEP FOXN1 subgroup (Pilot, date of approval xx/xx/2024).
Met criteria codes
PVS1
The NM_001369369.1:c.246C>A (p.Cys82Ter) variant in FOXN1 is a nonsense variant that is predicted to cause a premature stop codon in biologically relevant exon 3/9 that leads to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism (PVS1).
PP4
At least one patient (P9 of PMID: 33464451) with this variant displayed alopecia (0.25 pts) and low t-cell numbers (less than 1,000,000 cells/L; 0.5pts). The patient had whole exome sequencing (0.5pt) Total 1.25pt (PP4). The patient also had poor proliferative response to phytohemagglutinin on total cells, while it was normal when evaluated on separated T cells, flow cytometric analysis showed near complete absence of CD45RA+ CD4 T cells, and they had very low TRECs. They received a thymus transplant but T cell levels were not reported post transplant. Interestingly the patients alopecia spontaneously reversed at age 3.
PM2_Supporting
This variant is absent from gnomAD v4.1 (PM2_Supporting).
Not Met criteria codes
PM3
the patient is compound heterozygous with likely pathogenic variant NM_001369369.1(FOXN1):c.1049C>T (p.Pro350Leu), confirmation of trans phase not reported. Not considered here to avoid circularity.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.